Authors:
Hadano, S
Hand, CK
Osuga, H
Yanagisawa, Y
Otomo, A
Devon, RS
Miyamoto, N
Showguchi-Miyata, J
Okada, Y
Singaraja, R
Figlewicz, DA
Kwiatkowski, T
Hosler, BA
Sagie, T
Skaug, J
Nasir, J
Brown, RH
Scherer, SW
Rouleau, GA
Hayden, MR
Ikeda, JE
Citation: S. Hadano et al., A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 (vol 29, pg 166, 2001), NAT GENET, 29(3), 2001, pp. 352-352
Authors:
Hadano, S
Hand, CK
Osuga, H
Yanagisawa, Y
Otomo, A
Devon, RS
Miyamoto, N
Showguchi-Miyata, J
Okada, Y
Singaraja, R
Figlewicz, DA
Kwiatkowski, T
Hosler, BA
Sagie, T
Skaug, J
Nasir, J
Brown, RH
Scherer, SW
Rouleau, GA
Hayden, MR
Ikeda, JE
Citation: S. Hadano et al., A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2, NAT GENET, 29(2), 2001, pp. 166-173
Authors:
Peel, AL
Rao, RV
Cottrell, BA
Hayden, MR
Ellerby, LM
Bredesen, DE
Citation: Al. Peel et al., Double-stranded RNA-dependent protein kinase, PKR, binds preferentially toHuntington's disease (HD) transcripts and is activated in HD tissue, HUM MOL GEN, 10(15), 2001, pp. 1531-1538
Authors:
Emsley, RA
Niehaus, DJH
Mbanga, NI
Oosthuizen, PP
Stein, DJ
Maritz, JS
Pimstone, SN
Hayden, MR
Laurent, C
Deleuze, JF
Mallet, J
Citation: Ra. Emsley et al., The factor structure for positive and negative symptoms in South African Xhosa patients with schizophrenia, SCHIZOPHR R, 47(2-3), 2001, pp. 149-157
Authors:
Hadano, S
Yanagisawa, Y
Skaug, J
Fichter, K
Nasir, J
Martindale, D
Koop, BF
Scherer, SW
Nicholson, DW
Rouleau, GA
Ikeda, JE
Hayden, MR
Citation: S. Hadano et al., Cloning and characterization of three novel genes, ALS2CR1, ALS2CR2, and ALS2CR3, in the juvenile amyotrophic lateral sclerosis (ALS2) critical region at chromosome 2q33-q34: Candidate genes for ALS2, GENOMICS, 71(2), 2001, pp. 200-213
Authors:
Zuccato, C
Ciammola, A
Rigamonti, D
Leavitt, BR
Goffredo, D
Conti, L
MacDonald, ME
Friedlander, RM
Silani, V
Hayden, MR
Timmusk, T
Sipione, S
Cattaneo, E
Citation: C. Zuccato et al., Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease, SCIENCE, 293(5529), 2001, pp. 493-498
Authors:
Clarke, G
Collins, RA
Leavitt, BR
Andrews, DF
Hayden, MR
Lumsden, CJ
McInnes, RR
Citation: G. Clarke et al., A one-hit model of cell death in inherited neuronal degenerations (vol 406, pg 195, 2000), NATURE, 409(6819), 2001, pp. 542
Authors:
Holbert, S
Denghien, I
Kiechle, T
Rosenblatt, A
Wellington, C
Hayden, MR
Margolis, RL
Ross, CA
Dausset, J
Ferrante, RJ
Neri, C
Citation: S. Holbert et al., The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: Neuropathologic and genetic evidence for a role in Huntington's diseasepathogenesis, P NAS US, 98(4), 2001, pp. 1811-1816
Citation: Ad. Attie et al., Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis, J LIPID RES, 42(11), 2001, pp. 1717-1726
Authors:
Metzler, M
Legendre-Guillemin, V
Gan, L
Chopra, V
Kwok, A
McPherson, PS
Hayden, MR
Citation: M. Metzler et al., HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2, J BIOL CHEM, 276(42), 2001, pp. 39271-39276
Authors:
Singaraja, RR
Bocher, V
James, ER
Clee, SM
Zhang, LH
Leavitt, BR
Tan, B
Brooks-Wilson, A
Kwok, A
Bissada, N
Yang, YZ
Liu, GQ
Tafuri, SR
Fievet, C
Wellington, CL
Staels, B
Hayden, MR
Citation: Rr. Singaraja et al., Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1, J BIOL CHEM, 276(36), 2001, pp. 33969-33979
Authors:
McGladdery, SH
Pimstone, SN
Clee, SM
Bowden, JF
Hayden, MR
Frohlich, JJ
Citation: Sh. Mcgladdery et al., Common mutations in the lipoprotein lipase gene (LPL): effects on HDL-cholesterol levels in a Chinese Canadian population, ATHEROSCLER, 156(2), 2001, pp. 401-407
Authors:
Clee, SM
Loubser, O
Collins, J
Kastelein, JJP
Hayden, MR
Citation: Sm. Clee et al., The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease, CLIN GENET, 60(4), 2001, pp. 293-300
Authors:
Almqvist, EW
Elterman, DS
MacLeod, PM
Hayden, MR
Citation: Ew. Almqvist et al., High incidence rate and absent family histories in one quarter of patientsnewly diagnosed with Huntington disease in British Columbia, CLIN GENET, 60(3), 2001, pp. 198-205
Authors:
Otto, CJ
Almqvist, E
Hayden, MR
Andrew, SE
Citation: Cj. Otto et al., The 'flap' endonuclease gene FEN1 is excluded as a candidate gene implicated in the CAG repeat expansion underlying Huntington disease, CLIN GENET, 59(2), 2001, pp. 122-127
Authors:
Clee, SM
Zwinderman, AH
Engert, JC
Zwarts, KY
Molhuizen, HOF
Roomp, K
Jukema, JW
van Wijland, M
van Dam, M
Hudson, TJ
Brooks-Wilson, A
Genest, J
Kastelein, JJ
Hayden, MR
Citation: Sm. Clee et al., Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease, CIRCULATION, 103(9), 2001, pp. 1198-1205
Authors:
Backus, RC
Ginzinger, DG
Excoffon, KJDA
Clee, SM
Hayden, MR
Eckel, RH
Hickman, MA
Rogers, QR
Citation: Rc. Backus et al., Maternal expression of functional lipoprotein lipase and effects on body fat mass and body condition scores of mature cats with lipoprotein lipase deficiency, AM J VET RE, 62(2), 2001, pp. 264-269
Authors:
Falush, D
Almqvist, EW
Brinkmann, RR
Iwasa, Y
Hayden, MR
Citation: D. Falush et al., Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases, AM J HU GEN, 68(2), 2001, pp. 373-385
Authors:
Lu, GQ
Excoffon, KJDA
Wilson, JE
McManus, BM
Rogers, QR
Miao, L
Kastelein, JJP
Lewis, MES
Hayden, MR
Citation: Gq. Lu et al., Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer, HUM GENE TH, 11(1), 2000, pp. 21-32